Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $3.4 Million - $4.82 Million
-13,300 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $2.44 Million - $3 Million
-6,544 Reduced 32.98%
13,300 $5.49 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $1.74 Million - $3.15 Million
17,637 Added 799.14%
19,844 $2.51 Million
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $231,933 - $302,866
2,207 New
2,207 $250,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Shanda Asset Management Holdings LTD Portfolio

Follow Shanda Asset Management Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.